Search Results

Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Gopi Natarajan to the Board of Directors.

GeminiBio (“Seller”) governs all transactions with purchasers (“Buyers”) through these Terms and Conditions, together with any Order Confirmations, forming the entire agreement. Orders and optional services—like heat-inactivation—must be clearly specified; otherwise, they are not included.

Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, and BroadOak Capital Partners, a life science focused investment firm, announced today the appointment of Bryan Poltilove to the Board of Directors.

GeminiBio opens new cGMP bioprocess liquid manufacturing facility, expanding capabilities to better serve the biotechnology and cell & gene therapy markets

Asahi Kasei Bioprocess America and GeminiBio enter strategic partnership to advance application of Inline Buffer Formulation and streamline biopharmaceutical manufacturing processes. The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and speed to market. • Costs for biopharmaceutical production can be significantly reduced, positively affecting the accessibility of medication for patients globally. • This partnership will be a catalyst for innovation at both companies, driving new industry standards.